Topic

Chris Spivey is the editorial director of 

Articles

This new pioneering phase of mRNA is loaded with potential, but also obstacles and false dawns. 

The Commercial Message mRNA Products Send

Coverage of COVID-19 vaccines was surprisingly displaced by this year’s astounding oncology and iconoclastic gene therapy “cures.”

Pedestrians as Priority

mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.

mRNA Hauptbahnhof

Content is king in publishing, but interpretation is imperator.

Conference Time Brings Gifts

One can only learn the secrets of "fight club" by attending its meetings.

Industry’s Best Secret

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

Vaccine Disconnect

Promising applications for targeted delivery may be cresting the horizon.

Navigating the Future

As we reach further afield in the molecular universe, we encounter new types of problems to resolve.

From the Editor